ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

FDBK Feedback Plc

60.50
0.00 (0.00%)
19 Jul 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Feedback Plc LSE:FDBK London Ordinary Share GB00BJN59X09 ORD 50P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 60.50 60.00 61.00 60.50 60.50 60.50 14,770 07:44:37
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
Electronic Computers 1.03M -2.92M -0.2188 -2.77 8.07M
Feedback Plc is listed in the Electronic Computers sector of the London Stock Exchange with ticker FDBK. The last closing price for Feedback was 60.50p. Over the last year, Feedback shares have traded in a share price range of 58.00p to 150.00p.

Feedback currently has 13,334,659 shares in issue. The market capitalisation of Feedback is £8.07 million. Feedback has a price to earnings ratio (PE ratio) of -2.77.

Feedback Share Discussion Threads

Showing 7076 to 7098 of 14875 messages
Chat Pages: Latest  295  294  293  292  291  290  289  288  287  286  285  284  Older
DateSubjectAuthorDiscuss
12/10/2019
10:56
Cheers Ged, 7 hours and counting! Will you be watching?
ducatiman
12/10/2019
10:53
Texrad was cited in the article in Nature article above GED.
So I assumed so.

hazl
12/10/2019
10:24
Good luck today, Ducatiman.

There might be a good question in there. Soupdragon on IQAI thread wrote:-

"Also worth the note that hospitals with dual ct scan equipment won’t bother with stonechecker as they can do what it does already."

Which raises the question:-

"If the version of Stonechecker that got FDA clearance (edited from approval) uses TexRAD I'm sure it would be an improvement. Would dual ct scan equipment provide textural analysis?"

Do we know for sure that the version of StoneChecker that got FDA clearance uses TexRAD?

ged5
11/10/2019
19:49
Couldn't see the point of posting the research article over here as it is about StoneChecker. Still if it makes you happy, you go for it girl.
lr2
11/10/2019
19:39
As posted over on IQAI thought that somebody must have forgotten that it would be useful over here too as Texrad is mentioned in the article.
hazl
11/10/2019
11:07
Morning Bob. Good speculation but I thought it might be a little early for Bleepa contract announcement so that would be extremely good news. What do others think?

TexRAD incorporated into Bleepa and the process started for FDA clearance would be excellent.

ged5
11/10/2019
11:01
Morning Ged, my take is that TO would like to announce a deal for Bleepa with his update. If this was not likely then I think he would have made an announcement by now. The fact he hasn�t indicates to me that a contract is imminent ie within the next couple of weeks. May be wrong but that�s my read.
Then of course we are due an update on TexRAD and Inwonder if this will include FDA status and possibly another incarnation to sit alongside TexRAD Lung? All speculation but much to label as potential.

bobd29
11/10/2019
10:59
I see you've been involved in Saving Private Ryan. Good work!

I thought they were buys but good to see it confirmed.

ged5
11/10/2019
09:10
as per yesterdays post
hazl
11/10/2019
09:07
I'd expected an announcement by this week. It can't be too long before we get an update.

Not sure if the ISO significance, ie making FDA clearance easier, has been picked up by the market yet.

ged5
10/10/2019
20:04
All mine in the red currently dave
ducatiman
10/10/2019
19:55
Good to hear.

But have to learn to ride a good winner as well. Used to do that in the old days. Now it's a bit harder when so many stocks you hold are dropping that you bail out of your winner to offset losses elsewhere...a huge mistake.

dave4545
10/10/2019
19:47
Good luck Dave, I think the potential here is enormous compared to IQAI.
ducatiman
10/10/2019
19:45
Indeed so bob, along with stonechecker approval there shouldn't be an issue with Texrad. I wonder if we are actually in the process? Should also make approval for bleepa easy after we get the CE Mark.
ducatiman
10/10/2019
19:21
I bought Iqai at 1.2p. I sold it at 1.9p, it went to 16p high.

fwiw I bought some FDBK today at 1.2p :-))

dave4545
10/10/2019
19:07
Hi Duc, that is very significant imo if indeed it does lead to easier FDA approval, we have seen with IQAI what can happen to the share price then. Either way it cements the quality of Bleepa and should make sales/compliance more appealing.
bobd29
10/10/2019
17:50
Lol Ged, it doesn't bother me. Bloody kids these days eh?
ducatiman
10/10/2019
17:44
What's the point of marking that post (3626) down. Is it factually incorrect? Do you require a link? Do you not like Ducatiman?

Whatever it is say so and stop being silly.

ged5
10/10/2019
17:28
ISO 13485:2016 is the internationally recognised 'Medical Devices Quality Management' standard specifying that organisations demonstrate their ability to provide medical devices and related services that consistently meet customer and regulatory requirements.

Feedback Medical Ltd's continued compliance with this standard illustrates the importance that it places on the quality of its products and customer support. The certification was awarded following a surveillance audit by independent compliance specialists SGS UK Ltd.

ducatiman
10/10/2019
16:28
Very quiet day with low volume but for how long?

That is a significant piece of news. Pieces coming together.

ged5
10/10/2019
15:19
ISO 13485 - useful if you are looking for FDA approval.
lr2
10/10/2019
15:15
From your link:-

Bleepa is an application whose task is to improve communication between medical personnel while ensuring the safety of medical data of patients, especially: medical imaging data. The app had its premiere on September 4 at the NHS England Health and Care Innovation Expo in Manchester.
Features of the application

The application allows real-time sharing of DICOM files. Doctors can use it to mark areas that they think require special attention and comment on specific areas of the image.
Medical communication: it allows medical staff to communicate with each other.
Bleepa is also a DICOM file viewer � it is not just a messenger, it combines advanced radiological functionalities.

Importantly, the application is being developed in accordance with ISO 13485, which will make it easier for the client to obtain certification afterwards.

ged5
10/10/2019
14:37
Future Processing & Bleepa.
lr2
Chat Pages: Latest  295  294  293  292  291  290  289  288  287  286  285  284  Older

Your Recent History

Delayed Upgrade Clock